Axovant Sciences Ltd (NASDAQ:AXON)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $3.40 and traded as high as $5.05. Axovant Sciences shares last traded at $4.62, with a volume of 1,111,836 shares traded.
The stock’s 50-day simple moving average is $3.43 and its two-hundred day simple moving average is $3.47. The company has a debt-to-equity ratio of 1.24, a quick ratio of 2.02 and a current ratio of 2.02. The stock has a market cap of $552.70 million, a price-to-earnings ratio of -2.19 and a beta of 1.21.
Axovant Sciences Company Profile (NASDAQ:AXON)
Axovant Sciences Ltd., a clinical-stage biopharmaceutical company, engages in acquisition, development, and commercialization of therapeutics in the fields of neurology and psychiatry in the United States and the European Union. It focuses on developing AXO-Lenti-PD, an in vivo lentiviral gene therapy investigational product candidate for the one-time treatment of Parkinson's disease.
See Also: What is intrinsic value?
Receive News & Ratings for Axovant Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axovant Sciences and related companies with MarketBeat.com's FREE daily email newsletter.